Biotech Values

[DewDiligence]

Would even one “program” in PP’s “pipeline” be funded by a top-tier pharmaceutical company if it were in their possession?

I doubt it.

Will even one program in PP’s pipeline be the impetus for a major partnership transaction during the next decade?

I doubt it.

Will even one program in PP’s pipeline ever produce a drug that is approved for marketing in the US or European Union?

I think not.

But wait—PP did somehow manage to generate an NDA submission for the Coprexa program… doesn’t this make the company semi-legitimate?

No, it does not—the FDA told PP to take their Coprexa NDA and shove it.

Prediction: If any product akin to what PP trumpets to investors on its conference calls ever comes to fruition, it will be in spite of what PP is doing, not because of it.